At present, the Imaging Core of the Center for Cardiovascular Research houses one Olympus laser scanning? confocal microscope (Fluoview FV300) equipped with Krypton, Argon and He/Ne lasers for confocal microscopy? and Mercury and Halogen lamps for epifluorescence and DIC/phase contrast/bright field microscopy, respectively.? The confocal unit is mounted on an inverted Olympus microscope (1X70) with a universal high NA condenser. For? capturing non-confocal images, a Spot CCD camera is used. This confocal microscope will be used for the? proposed PPG projects.? There is an up-right Olympus microscope (BX51) for epifluorescence, phase contrast, and DIC? observations. The scope is also equipped with a Spot CCD camera. This scope is used for routine? immunofluorescence observations, especially for en face analyses of immunostained endothelial tissue.? Specimens for immunofluorescence microscopy are prepared by individual investigators. Technical? suggestions and advice are given to them, such as fixation and staining conditions, blocking, and mounting. Data? acquisition is done with the help of the Core Director and an assistant using a TV monitor. Those who wish to use? the scopes by themselves are given instructions by the Core Director.? MCID Elite 6.0 (Imaging Research Inc.) is available for the studies proposed in this application. The? software is capable of performing various forms of image analyses such as image enhancement, image processing? and editing, and 3D reconstruction. It has also functions that are quantitative such as profiling (vertical, horizontal,? rotatable, and user-traced lane definition), stereology for unbiased morphological measurements and quantification,? and grain counting. The grain counting mode is applicable to cells, grains, organelles, and other discrete objects.? Valid targets are discriminated from background based on their intensity, color and spatial criteria.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL077789-02
Application #
7429101
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2006-08-01
Project End
2010-07-31
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2006
Total Cost
$123,978
Indirect Cost
Name
University of Rochester
Department
Type
DUNS #
041294109
City
Rochester
State
NY
Country
United States
Zip Code
14627
Heo, Kyung-Sun; Le, Nhat-Tu; Cushman, Hannah J et al. (2015) Disturbed flow-activated p90RSK kinase accelerates atherosclerosis by inhibiting SENP2 function. J Clin Invest 125:1299-310
Heo, Kyung-Sun; Fujiwara, Keigi; Abe, Jun-ichi (2014) Shear stress and atherosclerosis. Mol Cells 37:435-40
Le, Nhat-Tu; Heo, Kyung-Sun; Takei, Yuichiro et al. (2013) A crucial role for p90RSK-mediated reduction of ERK5 transcriptional activity in endothelial dysfunction and atherosclerosis. Circulation 127:486-99
Heo, Kyung-Sun; Chang, Eugene; Takei, Yuichiro et al. (2013) Phosphorylation of protein inhibitor of activated STAT1 (PIAS1) by MAPK-activated protein kinase-2 inhibits endothelial inflammation via increasing both PIAS1 transrepression and SUMO E3 ligase activity. Arterioscler Thromb Vasc Biol 33:321-9
Knight, W E; Yan, C (2012) Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects. Horm Metab Res 44:766-75
Wang, Xiao-Qun; Nigro, Patrizia; World, Cameron et al. (2012) Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2. Circ Res 110:560-8
Dhawan, Latika; Liu, Bin; Pytlak, Allison et al. (2012) Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells. Mol Cell Biol 32:3768-75
Lim, Jae Hyang; Jono, Hirofumi; Komatsu, Kensei et al. (2012) CYLD negatively regulates transforming growth factor-?-signalling via deubiquitinating Akt. Nat Commun 3:771
Cai, Yujun; Knight, Walter E; Guo, Shujie et al. (2012) Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J Pharmacol Exp Ther 343:479-88
Le, Nhat-Tu; Takei, Yuichiro; Shishido, Tetsuro et al. (2012) p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction. Circ Res 110:536-50

Showing the most recent 10 out of 50 publications